High SARS-CoV-2 Viral Load and Low CCL5 Expression Levels in the Upper Respiratory Tract Are Associated With COVID-19 Severity

J Infect Dis. 2022 Mar 15;225(6):977-982. doi: 10.1093/infdis/jiab604.

Abstract

Mucosal immune response in the upper respiratory tract is crucial for initial control of viral replication, clearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and progression of coronavirus disease 2019 (COVID-19). We analyzed SARS-CoV-2 RNA load and expression of selected immune genes in the upper respiratory tract (nasopharynx) of 255 SARS-CoV-2-infected patients and evaluated their association with severe COVID-19. SARS-CoV-2 replication in nasopharyngeal mucosa induces expression of several innate immune genes. High SARS-CoV-2 viral load and low CCL5 expression levels were associated with intensive care unit admission or death, although CCL5 was the best predictor of COVID-19 severity.

Keywords: CCL5; COVID-19; ICU; SARS-CoV-2; death; gene expression; innate immunity; nasopharynx; viral load.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / diagnosis
  • COVID-19* / mortality
  • Chemokine CCL5 / genetics*
  • Chemokine CCL5 / metabolism
  • Humans
  • Intensive Care Units
  • Nasopharynx / virology*
  • RNA, Viral / genetics
  • SARS-CoV-2*
  • Severity of Illness Index
  • Viral Load

Substances

  • CCL5 protein, human
  • Chemokine CCL5
  • RNA, Viral